Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 29 | 2020 | 207 | 9.540 |
Why?
|
| Stroke | 15 | 2022 | 261 | 5.280 |
Why?
|
| Cerebral Hemorrhage | 9 | 2023 | 94 | 3.170 |
Why?
|
| Ischemic Attack, Transient | 7 | 2020 | 27 | 2.800 |
Why?
|
| Platelet Count | 11 | 2019 | 112 | 2.540 |
Why?
|
| Platelet Activation | 9 | 2019 | 55 | 2.400 |
Why?
|
| Cognition Disorders | 8 | 2019 | 186 | 2.220 |
Why?
|
| Subarachnoid Hemorrhage | 5 | 2022 | 60 | 1.980 |
Why?
|
| Copper | 8 | 2011 | 49 | 1.870 |
Why?
|
| Aged | 41 | 2025 | 5648 | 1.760 |
Why?
|
| Cognitive Dysfunction | 8 | 2024 | 271 | 1.650 |
Why?
|
| Middle Aged | 42 | 2025 | 7496 | 1.630 |
Why?
|
| Brain Ischemia | 5 | 2020 | 89 | 1.550 |
Why?
|
| Brain Infarction | 4 | 2015 | 10 | 1.520 |
Why?
|
| Male | 53 | 2025 | 14127 | 1.520 |
Why?
|
| Alzheimer Disease | 8 | 2021 | 225 | 1.510 |
Why?
|
| Blood Coagulation | 4 | 2019 | 120 | 1.430 |
Why?
|
| Veterans | 3 | 2019 | 69 | 1.370 |
Why?
|
| Humans | 75 | 2025 | 29214 | 1.360 |
Why?
|
| Female | 49 | 2025 | 15826 | 1.340 |
Why?
|
| Carotid Stenosis | 3 | 2014 | 28 | 1.260 |
Why?
|
| Aged, 80 and over | 19 | 2025 | 2070 | 1.180 |
Why?
|
| Facial Expression | 5 | 2013 | 17 | 1.140 |
Why?
|
| Cognition | 6 | 2025 | 331 | 1.120 |
Why?
|
| Risk Factors | 16 | 2020 | 2144 | 1.100 |
Why?
|
| Emotions | 5 | 2013 | 139 | 0.980 |
Why?
|
| Hypertension | 6 | 2023 | 309 | 0.960 |
Why?
|
| Platelet Aggregation Inhibitors | 4 | 2020 | 191 | 0.910 |
Why?
|
| Functional Laterality | 4 | 2013 | 64 | 0.900 |
Why?
|
| Adult | 19 | 2019 | 8131 | 0.790 |
Why?
|
| Serotonin Uptake Inhibitors | 4 | 2019 | 26 | 0.780 |
Why?
|
| Dementia | 4 | 2023 | 98 | 0.720 |
Why?
|
| Amyloid beta-Protein Precursor | 4 | 2011 | 34 | 0.690 |
Why?
|
| Pilot Projects | 10 | 2025 | 467 | 0.690 |
Why?
|
| Dementia, Vascular | 2 | 2019 | 57 | 0.690 |
Why?
|
| Intracranial Hemorrhages | 2 | 2025 | 32 | 0.690 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2019 | 77 | 0.680 |
Why?
|
| Vitamin B 12 Deficiency | 3 | 2009 | 9 | 0.630 |
Why?
|
| Pattern Recognition, Visual | 3 | 2013 | 37 | 0.630 |
Why?
|
| Stroke, Lacunar | 1 | 2020 | 3 | 0.620 |
Why?
|
| Thrombin | 7 | 2017 | 69 | 0.600 |
Why?
|
| Intracranial Embolism | 1 | 2019 | 6 | 0.600 |
Why?
|
| Amnesia | 2 | 2011 | 9 | 0.600 |
Why?
|
| Severity of Illness Index | 3 | 2017 | 468 | 0.580 |
Why?
|
| Aneurysm | 1 | 2019 | 26 | 0.580 |
Why?
|
| Predictive Value of Tests | 5 | 2020 | 485 | 0.570 |
Why?
|
| Valsalva Maneuver | 1 | 2018 | 8 | 0.570 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 136 | 0.570 |
Why?
|
| Cerebrovascular Circulation | 2 | 2019 | 227 | 0.570 |
Why?
|
| Lymphocytes | 1 | 2019 | 96 | 0.550 |
Why?
|
| Time Factors | 7 | 2025 | 1619 | 0.540 |
Why?
|
| Collagen | 6 | 2017 | 157 | 0.510 |
Why?
|
| Microcirculation | 1 | 2017 | 113 | 0.490 |
Why?
|
| Platelet Transfusion | 1 | 2016 | 29 | 0.480 |
Why?
|
| Microvessels | 1 | 2017 | 99 | 0.470 |
Why?
|
| Smoking | 4 | 2019 | 480 | 0.470 |
Why?
|
| Face | 2 | 2013 | 26 | 0.460 |
Why?
|
| Brain Concussion | 1 | 2015 | 53 | 0.440 |
Why?
|
| Spinal Cord Diseases | 2 | 2006 | 33 | 0.440 |
Why?
|
| Carotid Artery, Internal | 1 | 2014 | 19 | 0.430 |
Why?
|
| Asymptomatic Diseases | 1 | 2014 | 17 | 0.420 |
Why?
|
| Activities of Daily Living | 2 | 2015 | 107 | 0.420 |
Why?
|
| Brain Injuries | 1 | 2014 | 50 | 0.420 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 56 | 0.420 |
Why?
|
| Carotid Artery Diseases | 1 | 2014 | 37 | 0.420 |
Why?
|
| Indians, North American | 1 | 2019 | 548 | 0.410 |
Why?
|
| Medication Adherence | 1 | 2014 | 48 | 0.410 |
Why?
|
| Smoking Cessation | 1 | 2019 | 431 | 0.400 |
Why?
|
| Social Perception | 1 | 2013 | 23 | 0.400 |
Why?
|
| Visual Fields | 1 | 2013 | 35 | 0.400 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 110 | 0.400 |
Why?
|
| Cross-Sectional Studies | 6 | 2024 | 1013 | 0.390 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2023 | 847 | 0.390 |
Why?
|
| Zinc | 3 | 2004 | 63 | 0.380 |
Why?
|
| Aspirin | 2 | 2019 | 125 | 0.380 |
Why?
|
| Attention | 1 | 2013 | 91 | 0.380 |
Why?
|
| Enteric Nervous System | 1 | 2011 | 10 | 0.360 |
Why?
|
| Demyelinating Diseases | 2 | 2002 | 6 | 0.350 |
Why?
|
| Diabetes Complications | 2 | 2019 | 66 | 0.340 |
Why?
|
| Risk Assessment | 3 | 2019 | 632 | 0.330 |
Why?
|
| Ceruloplasmin | 2 | 2009 | 10 | 0.330 |
Why?
|
| Nervous System Diseases | 1 | 2011 | 40 | 0.330 |
Why?
|
| Intestines | 1 | 2011 | 121 | 0.330 |
Why?
|
| Prospective Studies | 5 | 2023 | 1288 | 0.320 |
Why?
|
| Platelet Function Tests | 3 | 2015 | 24 | 0.310 |
Why?
|
| Cerebral Infarction | 1 | 2010 | 26 | 0.310 |
Why?
|
| Sertraline | 1 | 2009 | 5 | 0.310 |
Why?
|
| Aphasia | 1 | 2009 | 5 | 0.310 |
Why?
|
| Recurrence | 3 | 2020 | 328 | 0.300 |
Why?
|
| Frontotemporal Dementia | 1 | 2009 | 4 | 0.300 |
Why?
|
| Disease Progression | 5 | 2023 | 484 | 0.300 |
Why?
|
| Mental Status and Dementia Tests | 2 | 2019 | 14 | 0.290 |
Why?
|
| Gastrectomy | 1 | 2009 | 21 | 0.290 |
Why?
|
| Case-Control Studies | 5 | 2015 | 741 | 0.280 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2008 | 2 | 0.280 |
Why?
|
| Myelin Proteins | 1 | 2008 | 13 | 0.280 |
Why?
|
| Prognosis | 3 | 2017 | 817 | 0.280 |
Why?
|
| Point Mutation | 1 | 2008 | 61 | 0.270 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 2 | 2022 | 216 | 0.270 |
Why?
|
| Regression Analysis | 2 | 2019 | 212 | 0.270 |
Why?
|
| Blood Coagulation Factors | 1 | 2008 | 31 | 0.270 |
Why?
|
| Neurodegenerative Diseases | 2 | 2007 | 25 | 0.270 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 79 | 0.250 |
Why?
|
| Budesonide | 1 | 2006 | 2 | 0.250 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2006 | 2 | 0.250 |
Why?
|
| Referral and Consultation | 1 | 2007 | 98 | 0.250 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 1033 | 0.240 |
Why?
|
| Dietary Supplements | 2 | 2025 | 274 | 0.240 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2015 | 26 | 0.240 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2003 | 28 | 0.230 |
Why?
|
| Thrombectomy | 1 | 2025 | 30 | 0.230 |
Why?
|
| Time-to-Treatment | 1 | 2025 | 33 | 0.220 |
Why?
|
| Niacinamide | 1 | 2025 | 32 | 0.220 |
Why?
|
| Aging | 2 | 2017 | 1041 | 0.220 |
Why?
|
| Endovascular Procedures | 1 | 2025 | 77 | 0.210 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 526 | 0.210 |
Why?
|
| NAD | 1 | 2025 | 104 | 0.210 |
Why?
|
| Public Health | 2 | 2022 | 98 | 0.210 |
Why?
|
| Postoperative Complications | 1 | 2009 | 643 | 0.210 |
Why?
|
| Diabetic Neuropathies | 1 | 2004 | 18 | 0.210 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2004 | 19 | 0.210 |
Why?
|
| Drug Therapy, Combination | 2 | 2019 | 210 | 0.200 |
Why?
|
| Pandemics | 2 | 2023 | 211 | 0.200 |
Why?
|
| Cohort Studies | 2 | 2017 | 903 | 0.200 |
Why?
|
| Basilar Artery | 1 | 2003 | 7 | 0.200 |
Why?
|
| Trigeminal Neuralgia | 1 | 2003 | 13 | 0.200 |
Why?
|
| Incidence | 3 | 2025 | 581 | 0.200 |
Why?
|
| Cerebral Small Vessel Diseases | 1 | 2023 | 14 | 0.190 |
Why?
|
| Odds Ratio | 2 | 2015 | 237 | 0.190 |
Why?
|
| Age Factors | 3 | 2019 | 740 | 0.190 |
Why?
|
| Peripheral Arterial Disease | 1 | 2025 | 144 | 0.190 |
Why?
|
| Neurovascular Coupling | 1 | 2024 | 154 | 0.190 |
Why?
|
| Young Adult | 3 | 2019 | 2877 | 0.190 |
Why?
|
| Migraine with Aura | 1 | 2002 | 2 | 0.180 |
Why?
|
| White Matter | 1 | 2023 | 90 | 0.180 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2014 | 484 | 0.180 |
Why?
|
| Chi-Square Distribution | 2 | 2015 | 145 | 0.180 |
Why?
|
| Dominance, Cerebral | 1 | 2001 | 10 | 0.180 |
Why?
|
| Longitudinal Studies | 2 | 2023 | 431 | 0.170 |
Why?
|
| Prevalence | 2 | 2022 | 526 | 0.170 |
Why?
|
| Treatment Outcome | 3 | 2025 | 2443 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2022 | 105 | 0.170 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2020 | 8 | 0.170 |
Why?
|
| Neuropsychological Tests | 3 | 2023 | 249 | 0.170 |
Why?
|
| Pre-Eclampsia | 1 | 2020 | 49 | 0.160 |
Why?
|
| Retrospective Studies | 3 | 2022 | 2662 | 0.160 |
Why?
|
| Central Nervous System Diseases | 1 | 2000 | 13 | 0.160 |
Why?
|
| Scalp | 1 | 2000 | 14 | 0.160 |
Why?
|
| United States | 3 | 2015 | 2270 | 0.150 |
Why?
|
| Flow Cytometry | 2 | 2014 | 292 | 0.150 |
Why?
|
| Mean Platelet Volume | 1 | 2019 | 5 | 0.150 |
Why?
|
| Cerebral Veins | 1 | 2019 | 11 | 0.150 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2009 | 100 | 0.150 |
Why?
|
| Cognitive Aging | 1 | 2019 | 22 | 0.140 |
Why?
|
| Warfarin | 1 | 2019 | 94 | 0.140 |
Why?
|
| Hyperlipidemias | 1 | 2019 | 38 | 0.140 |
Why?
|
| Swimming | 1 | 2018 | 32 | 0.140 |
Why?
|
| Skin Neoplasms | 1 | 2000 | 147 | 0.140 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2000 | 165 | 0.140 |
Why?
|
| Vascular Remodeling | 1 | 2017 | 14 | 0.130 |
Why?
|
| Matrix Metalloproteinases | 1 | 2017 | 31 | 0.130 |
Why?
|
| Surface Properties | 2 | 2008 | 134 | 0.130 |
Why?
|
| Memory | 1 | 2017 | 76 | 0.120 |
Why?
|
| Memory Disorders | 1 | 2017 | 50 | 0.120 |
Why?
|
| Hemodynamics | 1 | 2017 | 221 | 0.120 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 117 | 0.120 |
Why?
|
| Patient Admission | 1 | 2015 | 30 | 0.110 |
Why?
|
| Biomarkers | 1 | 2019 | 790 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 303 | 0.110 |
Why?
|
| Mortality | 1 | 2015 | 46 | 0.110 |
Why?
|
| Personal Satisfaction | 1 | 2015 | 31 | 0.110 |
Why?
|
| Hematologic Tests | 1 | 2014 | 7 | 0.110 |
Why?
|
| Logistic Models | 1 | 2015 | 415 | 0.110 |
Why?
|
| Inflammation | 1 | 2019 | 672 | 0.100 |
Why?
|
| Reference Values | 2 | 2007 | 200 | 0.100 |
Why?
|
| Cerebral Angiography | 1 | 2014 | 38 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 194 | 0.100 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 226 | 0.100 |
Why?
|
| Deficiency Diseases | 2 | 2006 | 6 | 0.100 |
Why?
|
| Analysis of Variance | 2 | 2007 | 393 | 0.100 |
Why?
|
| Constriction, Pathologic | 1 | 2013 | 36 | 0.100 |
Why?
|
| Animals | 3 | 2019 | 10806 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2012 | 39 | 0.090 |
Why?
|
| Brain | 3 | 2023 | 774 | 0.090 |
Why?
|
| Endothelium, Vascular | 2 | 2025 | 347 | 0.090 |
Why?
|
| Muscle, Smooth | 1 | 2011 | 41 | 0.090 |
Why?
|
| Eating | 1 | 2011 | 71 | 0.090 |
Why?
|
| Biological Transport | 1 | 2011 | 128 | 0.090 |
Why?
|
| Platelet Adhesiveness | 1 | 2011 | 7 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2012 | 274 | 0.080 |
Why?
|
| Electric Stimulation | 1 | 2011 | 256 | 0.080 |
Why?
|
| Body Weight | 1 | 2011 | 253 | 0.080 |
Why?
|
| Muscle Contraction | 1 | 2011 | 175 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 554 | 0.080 |
Why?
|
| Psychomotor Agitation | 1 | 2009 | 7 | 0.080 |
Why?
|
| Hostility | 1 | 2009 | 3 | 0.080 |
Why?
|
| Hyperhomocysteinemia | 1 | 2009 | 29 | 0.070 |
Why?
|
| Risk | 1 | 2009 | 138 | 0.070 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2008 | 3 | 0.070 |
Why?
|
| Rats | 1 | 2011 | 1595 | 0.070 |
Why?
|
| Family Health | 1 | 2008 | 71 | 0.070 |
Why?
|
| Pedigree | 1 | 2008 | 156 | 0.070 |
Why?
|
| Drug Utilization | 1 | 2008 | 28 | 0.070 |
Why?
|
| Vitamin B 12 | 1 | 2007 | 6 | 0.060 |
Why?
|
| Mental Status Schedule | 1 | 2007 | 9 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 82 | 0.060 |
Why?
|
| Comorbidity | 1 | 2008 | 261 | 0.060 |
Why?
|
| Interpersonal Relations | 1 | 2007 | 65 | 0.060 |
Why?
|
| Crohn Disease | 1 | 2006 | 32 | 0.060 |
Why?
|
| Crotalid Venoms | 1 | 2006 | 6 | 0.060 |
Why?
|
| Molecular Weight | 1 | 2006 | 122 | 0.060 |
Why?
|
| Lectins, C-Type | 1 | 2006 | 45 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2006 | 128 | 0.060 |
Why?
|
| Pyridinium Compounds | 1 | 2025 | 27 | 0.060 |
Why?
|
| Communication | 1 | 2007 | 185 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2025 | 191 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2008 | 1215 | 0.050 |
Why?
|
| Polyneuropathies | 1 | 2004 | 3 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2006 | 515 | 0.050 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2024 | 75 | 0.050 |
Why?
|
| Neutropenia | 1 | 2004 | 41 | 0.050 |
Why?
|
| Diabetic Foot | 1 | 2004 | 17 | 0.050 |
Why?
|
| Anemia | 1 | 2004 | 44 | 0.050 |
Why?
|
| Glucose Tolerance Test | 1 | 2004 | 60 | 0.050 |
Why?
|
| Low Back Pain | 1 | 2004 | 29 | 0.050 |
Why?
|
| Dilatation, Pathologic | 1 | 2003 | 11 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 55 | 0.050 |
Why?
|
| Coma | 1 | 2002 | 4 | 0.050 |
Why?
|
| Paresis | 1 | 2002 | 9 | 0.050 |
Why?
|
| Vasospasm, Intracranial | 1 | 2002 | 18 | 0.040 |
Why?
|
| Support Vector Machine | 1 | 2022 | 21 | 0.040 |
Why?
|
| ADAMTS13 Protein | 1 | 2022 | 126 | 0.040 |
Why?
|
| Radiography | 1 | 2002 | 203 | 0.040 |
Why?
|
| ROC Curve | 1 | 2022 | 144 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2004 | 216 | 0.040 |
Why?
|
| Mitochondria | 1 | 2025 | 419 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2025 | 692 | 0.040 |
Why?
|
| Anemia, Sideroblastic | 1 | 2000 | 2 | 0.040 |
Why?
|
| Necrosis | 1 | 2000 | 85 | 0.040 |
Why?
|
| Exercise Test | 1 | 2020 | 249 | 0.040 |
Why?
|
| Pregnancy | 1 | 2020 | 1261 | 0.030 |
Why?
|
| Child | 1 | 2002 | 2355 | 0.030 |
Why?
|
| Role | 1 | 2015 | 6 | 0.030 |
Why?
|
| Prosencephalon | 1 | 2007 | 7 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2007 | 124 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 2006 | 22 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 2006 | 54 | 0.010 |
Why?
|
| Forecasting | 1 | 2006 | 76 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2006 | 271 | 0.010 |
Why?
|
| Oklahoma | 1 | 2006 | 1063 | 0.010 |
Why?
|